{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:45:47Z","timestamp":1785757547111,"version":"3.56.0"},"reference-count":36,"publisher":"FapUNIFESP (SciELO)","issue":"7","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Scientific Research Projects Unit of the University of Health Sciences","award":["2021\/143"],"award-info":[{"award-number":["2021\/143"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"abstract":"<jats:p>SUMMARY  OBJECTIVE: The response to neoadjuvant therapy in patients with locally advanced rectal cancer varies considerably among individuals. While some patients achieve a complete pathological response, others may even experience disease progression during treatment. The aim of the study was to investigate the predictive value of serum adipokines in determining the response to neoadjuvant therapy.  METHODS: This prospective study included patients diagnosed with rectal cancer and scheduled for neoadjuvant therapy at our institution between September 2020 and September 2022. Before the treatment, blood samples were collected from the patients, and levels of serum adipokines (adiponectin, leptin, resistin, and adipsin) were measured. Following surgical resection, the Modified Ryan Scoring System was used to assess the response to neoadjuvant chemoradiotherapy. Patients were then divided into two groups according to the response to the treatment (Group 1: tumor regression grade 0; Group 2: tumor regression grade 1\u20133).  RESULTS: In the 58 patients included, no significant differences were observed in terms of demographics, tumor characteristics, or serum biochemical parameters. However, levels of adiponectin (p=0.039) and resistin (p=0.017) were significantly lower in the pathologic complete response group.  CONCLUSION: Adiponectin and resistin might contribute to anticipating response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer. The incorporation of these markers into personalized therapy approaches has the potential to improve correct decision-making in the management of locally advanced rectal cancer.<\/jats:p>","DOI":"10.1590\/1806-9282.20251705","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:00:26Z","timestamp":1785754826000},"source":"Crossref","is-referenced-by-count":0,"title":["The role of serum adipokines in predicting response to neoadjuvant therapy in patients with locally advanced rectal cancer"],"prefix":"10.1590","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6381-6726","authenticated-orcid":false,"given":"Husnu Ozan","family":"Sevik","sequence":"first","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-2077","authenticated-orcid":false,"given":"Omer","family":"Akay","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8790-9051","authenticated-orcid":false,"given":"Mert","family":"Guler","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9999-2959","authenticated-orcid":false,"given":"Anil","family":"Demir","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7132-6161","authenticated-orcid":false,"given":"Soykan","family":"Arikan","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8462-7809","authenticated-orcid":false,"given":"Oguz Ufuk","family":"Idiz","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-9714","authenticated-orcid":false,"given":"Mahsuni Mert","family":"Sevinc","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-2354","authenticated-orcid":false,"given":"Aziz","family":"Ari","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2538-8569","authenticated-orcid":false,"given":"Abdullah","family":"Sakin","sequence":"additional","affiliation":[{"name":"Bah\u00e7elievler Medipol Hospital,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0407-9655","authenticated-orcid":false,"given":"Cihad","family":"Tatar","sequence":"additional","affiliation":[{"name":"Acibadem Taksim Hospital,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1245\/s10434-018-07147-0","article-title":"The prognostic value of a pathologic complete response after neoadjuvant therapy for digestive cancer: systematic review and metaanalysis of 21 studies.","volume":"26","author":"Wan T","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3393\/ac.2022.00920.0131","article-title":"Total neoadjuvant therapy in rectal cancer: a network meta-analysis of randomized trials.","volume":"39","author":"Sychev S","year":"2023","journal-title":"Ann Coloproctol"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"e2414702","DOI":"10.1001\/jamanetworkopen.2024.14702","article-title":"Treatment of locally advanced rectal cancer in the era of total neoadjuvant therapy: a systematic review and network metaanalysis.","volume":"7","author":"Turri G","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41575-020-0275-y","article-title":"The multidisciplinary management of rectal cancer.","volume":"17","author":"Keller DS","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.ejso.2021.03.245","article-title":"Complete pathological response in rectal cancer utilising novel treatment strategies for neo-adjuvant therapy: a systematic review.","volume":"47","author":"Wilson K","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/SLA.0b013e3181fcb856","article-title":"Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study.","volume":"253","author":"Pucciarelli S","year":"2011","journal-title":"Ann Surg"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ejso.2014.03.021","article-title":"The effects of neoadjuvant chemoradiotherapy on physical fitness and morbidity in rectal cancer surgery patients.","volume":"40","author":"West MA","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000534815","article-title":"Is total neoadjuvant treatment beneficial for locally advanced rectal cancer? A meta-analysis of randomized controlled trials.","volume":"102","author":"Wu HQ","year":"2024","journal-title":"Oncology"},{"issue":"14","key":"ref9","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1002\/cam4.4051","article-title":"Associations between clinical characteristics and tumor response to neoadjuvant chemoradiotherapy in rectal cancer.","volume":"10","author":"Pang X","year":"2021","journal-title":"Cancer Med"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12964-024-01474-4","article-title":"Adipo-oncology: adipocyte-derived factors govern engraftment, survival, and progression of metastatic cancers.","volume":"22","author":"Sato S","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10555-022-10059-x","article-title":"The adipocyte microenvironment and cancer.","volume":"41","author":"Mukherjee A","year":"2022","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/apt.17045","article-title":"Review article: obesity and colorectal cancer.","volume":"56","author":"Bardou M","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/DCR.0b013e31828e5a72","article-title":"CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.","volume":"56","author":"Wallin U","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/jor.23598","article-title":"Serum creatinine and albumin predict sarcoma-specific survival in patients with myofibroblastic and fibroblastic sarcomas.","volume":"35","author":"Willegger M","year":"2017","journal-title":"J Orthop Res"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.6004\/jnccn.2018.7048","article-title":"A routine laboratory data-based model for predicting recurrence after curative resection of stage II colorectal cancer.","volume":"16","author":"Ye Z","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"ref16","first-page":"1043","article-title":"Effects of unidentified renal insufficiency on the safety and efficacy of chemotherapy for metastatic colorectal cancer patients: a prospective, observational study.","volume":"23","author":"Chen J","year":"2015","journal-title":"Support Care Cancer"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.7150\/jca.65677","article-title":"Nomogram incorporating preoperative testing markers for the prediction of early recurrence for colorectal liver metastases with neoadjuvant chemotherapy followed by hepatectomy.","volume":"13","author":"Chen Q","year":"2022","journal-title":"J Cancer"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.31557\/APJCP.2021.22.5.1607","article-title":"Predictive factors for pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.","volume":"22","author":"Zhang Q","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2008.08.002","article-title":"Effect of body mass index on shifts in ultrasound-based image-guided intensity-modulated radiation therapy for abdominal malignancies.","volume":"91","author":"Choi M","year":"2009","journal-title":"Radiother Oncol"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00066-011-0049-0","article-title":"Risk factors related to interfractional variation in whole pelvic irradiation for locally advanced pelvic malignancies.","volume":"188","author":"Yoon WS","year":"2012","journal-title":"Strahlenther Onkol"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.ejso.2017.07.022","article-title":"Impact of body mass index on treatment outcome of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.","volume":"43","author":"Sun Y","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"17588359221077972","DOI":"10.1177\/17588359221077972","article-title":"Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models.","volume":"14","author":"Li M","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fonc.2015.00286","article-title":"Predictors of complete response and disease recurrence following chemoradiation for rectal cancer.","volume":"5","author":"Bitterman DS","year":"2015","journal-title":"Front Oncol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/cancers13010016","article-title":"A comprehensive evaluation of associations between routinely collected staging information and the response to (Chemo)Radiotherapy in rectal cancer.","volume":"13","author":"Hammarstr\u00f6m K","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00384-013-1821-7","article-title":"Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.","volume":"29","author":"Garland ML","year":"2014","journal-title":"Int J Colorectal Dis"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/DCR.0b013e3182837e5b","article-title":"Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer.","volume":"56","author":"Huh JW","year":"2013","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1245\/s10434-012-2669-8","article-title":"Elevated CEA levels and low distance of the tumor from the anal verge are predictors of incomplete response to chemoradiation in patients with rectal cancer.","volume":"20","author":"Restivo A","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/jso.24358","article-title":"Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.","volume":"114","author":"Patel SV","year":"2016","journal-title":"J Surg Oncol"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/gutjnl-2013-304701","article-title":"Obesity and colorectal cancer.","volume":"62","author":"Bardou M","year":"2013","journal-title":"Gut"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/2211-5463.12751","article-title":"Effects of high-fat diet-induced adipokines and cytokines on colorectal cancer development.","volume":"9","author":"Zhang J","year":"2019","journal-title":"FEBS Open Bio"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"188419","DOI":"10.1016\/j.bbcan.2020.188419","article-title":"Resistin: an inflammatory cytokine with multi-faceted roles in cancer.","volume":"1874","author":"Sudan SK","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"7-8","key":"ref32","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.cca.2012.01.019","article-title":"The role of resistin in colorectal cancer.","volume":"413","author":"Danese E","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.3390\/ijms22062870","article-title":"Leptin and cancer: updated functional roles in carcinogenesis, therapeutic niches, and developments.","volume":"22","author":"Lin TC","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"10","key":"ref34","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/ijms20102519","article-title":"Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease.","volume":"20","author":"Parida S","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00595-016-1334-4","article-title":"Adiponectin and colorectal cancer.","volume":"47","author":"Otani K","year":"2017","journal-title":"Surg Today"},{"issue":"23","key":"ref36","doi-asserted-by":"crossref","first-page":"14982","DOI":"10.3390\/ijms232314982","article-title":"The role of adipokines in inflammatory mechanisms of obesity.","volume":"23","author":"Kirichenko TV","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302026000702208&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:00:29Z","timestamp":1785754829000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302026000702208&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026]]}},"alternative-id":["S0104-42302026000702208"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20251705","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20251705"}}